- The old versus the new: which do you keep in postoperative Crohn's disease?
-
Kotze PG, Ma C, Regueiro M, Panaccione R
- KMID: 2417687
- Intest Res.
- 2018 Apr;16(2):319-320.
- doi: 10.5217/ir.2018.16.2.319
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Preoperative use of anti-tumor necrosis factor therapy in Crohn's disease: promises and pitfalls
-
Kotze PG, Ghosh S, Bemelman W, Panaccione R
- KMID: 2425156
- Intest Res.
- 2017 Apr;15(2):160-165.
- doi: 10.5217/ir.2017.15.2.160
Recent advances in medical and surgical therapy were achieved during the last two decades in the management of Crohn's disease (CD). Anti-tumor necrosis factor (anti-TNF) agents are widely used worldwide.... -
- CITED
-
- Close
- SHARE
-
- Close
- Artificial intelligence in inflammatory bowel disease: implications for clinical practice and future directions
-
Ahmad HA, East JE, Panaccione R, Travis S, Canavan JB, Usiskin K, Byrne MF
- KMID: 2544752
- Intest Res.
- 2023 Jul;21(3):283-294.
- doi: 10.5217/ir.2023.00020
Inflammatory bowel disease encompasses Crohn’s disease and ulcerative colitis and is characterized by uncontrolled, relapsing, and remitting course of inflammation in the gastrointestinal tract. Artificial intelligence represents a new era... -
- CITED
-
- Close
- SHARE
-
- Close
